Fed. Circ. Affirms Lilly's Strattera Patent
The Federal Circuit on Friday upheld the validity of drugmaker Eli Lilly & Co.'s patent for attention deficit hyperactivity disorder drug Strattera, dealing a blow to Actavis Elizabeth LLC, Apotex Inc....To view the full article, register now.
Already a subscriber? Click here to view full article